AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$27.86
+2.73%Forward multiples
Based on analyst estimates
- P/E forward
- 8.65x
- P/E 2026E
- 9.43x
- P/E 2027E
- 8.81x
- P/E 2028E
- 8.30x
- P/S forward
- 1.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.01x
- PEG TTM
- 0.19x
- Price / book
- 1.54x
- Price / sales
- 1.62x
- Price / cash flow
- 6.42x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 2.17x
- EV / EBITDA
- 8.28x
- EV / EBIT
- 13.85x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026